One hundred and sixty seven isolates of staphylococci isolated from the inpatients of a tertiary care referral hospital in South India were speciated and activity of oxacillin, glycopeptides, linezolid and quinupristin/dalfopristin against these isolates was tested by broth microdilution method. Of the 114 coagulase negative staphylococci (CoNS), 49.1 % were S. haemolyticus, isolated predominantly from urine (64.6%), while the rest belonged to 11 other species. More than half the isolates of S. aureus (52.8%) and 68.4% of the CoNS were oxacillin resistant. All the strains were uniformly susceptible to vancomycin, linezolid and quinupristin/dalfopristin; but 25.6% isolates of S. haemolyticus showed reduced susceptibility to teicoplanin (MIC: 8-16 mg/L). Our study demonstrates the high prevalence of oxacillin resistance among hospital isolates of S. aureus and CoNS in India. Vancomycin, along with the newer agents like linezolid and quinupristin/dalfopristin remains the drug of choice for treating multi drug resistant staphylococcal infections.
c o m
Staphylococcus aureus and the coagulase negative nitrocefin disk (Becton Diskinson, Cockseyeville, MD, USA). Staphylococcus species (CoNS) are among the most common Minimum inhibitory concentration (MIC) test was performed causes of mortality and morbidity in the hospital setting by the NCCLS broth microdilution technique for oxacillin, worldwide. In 1995, Staphylococcus aureus was recovered from vancomycin, teicoplanin, linezolid and quinupristin/ 13% of infections and ranked as the most common cause of dalfopristin. 3 S. aureus ATCC 29213 was used as the reference nosocomial infection in the USA. 1 According to the most recent strain for the broth dilution technique. report from National Nosocomial Infections Surveillance, USA; S. aureus and CoNS constitute the most common nosocomial Results pathogens in both ICU and nonICU inpatient areas.
2 Given the Fifty-three (31.7%) of the strains were S. aureus while the importance of staphylococci in hospital setting, this study was remaining 114 (68.3%) belonged to various species of CoNS. done to find out the distribution of the various staphylococcal Twelve different species were identified among the CoNS, of species in this hospital. The prevalence of oxacillin resistance which S. haemolyticus was the most frequent isolate (82, 49.1%). among these isolates together with their susceptibility to glycopeptides and two newer agents (linezolid and quinupristin/ Table shows the source of the isolates and the species dalfopristin) was also investigated.
distribution. The majority of the S. haemolyticus isolates were from urine (53/82, 64.6%).
Materials and Methods
Antimicrobial resistance was found to be widespread among A total of 167 consecutive staphylococcal isolates from the isolates, with 142 strains (85.0%) showing β-lactamase various clinical specimens from the inpatients of a tertiary care hospital in India, were included in the study. in the hospital setting together with their susceptibility S. aureus and 68.4% of oxacillin resistant CoNS. These rates patterns have been reported in a number of studies. 4, 5 A few approximate the figures from India. 6, 7, 10 In the most recent studies from India have also highlighted this problem along report from USA in 2004, the average prevalence of MRSA with prevalence of antimicrobial resistance of the isolates from was 48.1% and 44.9% from ICU areas and non ICU areas health care settings.
6,7 In our study, majority of the isolates respectively; while the corresponding figures for CoNS was were CoNS and almost half of these isolates (82/167, 49.1%) 76.3% and 65.2% respectively.
2 Our figures correspond were S. haemolyticus. Some studies have shown similar roughly to the USA data as well. findings with this species as the predominant isolate among Among the newer anti-staphylococcal agents, all the strains in our study were sensitive to linezolid and quinupristin Interestingly, of the 71 staphylococci isolated from urine, / dalfopristin. A large scale study with these two agents have 53 (74.6%) were S. haemolyticus, making it the most common found them to be highly active against all isolates of Staphylococus species involved in nosocomial urinary tract Staphylococcus species, regardless of their resistance to infection in this hospital setting. One previous study has other agents.
11 However, one study has found 15 out of 658 reported similar finding, where the isolation rate of this (2.3%) isolates of CoNS being resistant to quinupristin/ organism was 47.8%. 4 In another study, S. haemolyticus was dalfopristin. 12 the predominant pathogen isolated from immunocompromised Ever since its introduction in 1984, vancomycin had stood the test of time as the last resort in treating multidrug resistant These findings are alarming since there is high prevalence staphylococcal infections, particularly those caused by of multidrug resistance in S. haemolyticus, particularly to the methicillin resistant strains. This reliability on vancomycin has glycopeptides.
9 This is due to the peculiar propensity of these been shaken in the last few years with isolated reports of organisms to develop resistance to glycopeptides in a single vancomycin resistance, which first originated from Japan and step upon exposure to these antibiotics. 9 In our study, reduced later on from USA and Europe. The emergence of S. aureus susceptibility to teicoplanin (MIC:8-16 mg/L) was noted strain that are hetero-intermediately resistant to vancomycin among 25.6% of the S. haemolyticus strains and not among (hVISA) has been reported recently originating from various the members of other species. Reduced susceptibility or Asian countries including India. 13 To counteract this potential resistance of staphylococci particularly S. haemolyticus for threat, newer agents like linezolid, daptomycin and the glycopeptide antibiotics has not been addressed quinupristin/dalfopristin have come into use. These agents, adequately in Indian studies. In the international multi-centre till now, have shown excellent activities against both S. aureus study RESIST in 1997 and 1998, 5 resistance to teicoplanin was and CoNS. Nonetheless, with the increasing use of these significant among methicillin resistant strains of CoNS, agents, we may encounter resistance to these drugs in future.
the CoNS. 4, 8 patients (45%). 8 particularly among S. haemolyticus. In our study, all the strains of Staphylococcus species were uniformly sensitive to vancomycin.
Methicillin resistance among staphylococci is widespread in India. In a multicentre study from India in 1996, 7 prevalence of MRSA ranged from 27% in Bombay to 47% in Bangalore and 42.5% in Delhi. A study from Eastern India in 2001 revealed 66.6% of S. epidermidis and 60% of S. haemolyticus strains resistant to oxacillin. 6 The most recent data from India gives a figure of 66% methicillin resistant CoNS among neonatal septicaemic patients; isolated from blood and skin of these patients. 10 As revealed in the present study, our hospital has a prevalence rate of 52.8% of oxacillin resistant It is important that large referral hospitals, particularly in countries like India, keep a continuous surveillance on the antimicrobial susceptibility pattern and the clinicians use these new agents judiciously to prevent antimicrobial resistance. ) .
